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Abstract
Background: Systematic reviews (SRs) of TCM have become increasingly popular in China and have been published in large
numbers. This review provides the first examination of epidemiological characteristics of these SRs as well as compliance
with the PRISMA and AMSTAR guidelines.
Objectives: To examine epidemiological and reporting characteristics as well as methodological quality of SRs of TCM
published in Chinese journals.
Methods: Four Chinese databases were searched (CBM, CSJD, CJFD and Wanfang Database) for SRs of TCM, from inception
through Dec 2009. Data were extracted into Excel spreadsheets. The PRISMA and AMSTAR checklists were used to assess
reporting characteristics and methodological quality, respectively.
Results: A total of 369 SRs were identified, most (97.6%) of which used the terms systematic review or meta-analysis in the
title. None of the reviews had been updated. Half (49.8%) were written by clinicians and nearly half (47.7%) were reported in
specialty journals. The impact factors of 45.8% of the journals published in were zero. The most commonly treated
conditions were diseases of the circulatory and digestive disease. Funding sources were not reported for any reviews. Most
(68.8%) reported information about quality assessment, while less than half (43.6%) reported assessing for publication bias.
Statistical mistakes appeared in one-third (29.3%) of reviews and most (91.9%) did not report on conflict of interest.
Conclusions: While many SRs of TCM interventions have been published in Chinese journals, the quality of these reviews is
troubling. As a potential key source of information for clinicians and researchers, not only were many of these reviews
incomplete, some contained mistakes or were misleading. Focusing on improving the quality of SRs of TCM, rather than
continuing to publish them in great quantity, is urgently needed in order to increase the value of these studies.
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Introduction
The first systematic review addressing the effect of traditional
Chinese medicine (TCM) that was published in a Chinese journal
may be sourced back to Chen et al. in 1999 [1]. Since then,
systematic reviews of TCM have become been increasingly
published in China, and now with a large number. Given the
implications of systematic reviews to policy making and clinical
practice, achieving highest possible quality in design, conduct,
analysis, and reporting is of paramount importance [2].
In the last decade, a few studies have examined the reporting of
systematic reviews, and found that the quality of reporting was
generally poor [3,4,5]. Three studies, using the Quality of
Reporting of Meta-analyses (QUOROM) checklist, examined
the quality of reporting of reviews of traditional Chinese medicine,
and concluded with similar findings [6,7,8] Nevertheless, they
were inherent with limitations, including the failure to report
details about epidemiological characteristics of included reviews,
and the failure to address methodological quality of those reviews.
In 2009, the newer standard of reporting systematic review, the
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) was released to replace the QUOROM for
guiding the review reporting [9]. Earlier than that, an instrument,
assisting the assessment of methodological quality of systematic
reviews, Assessment of Multiple Systematic Reviews (AMSTAR)
[10] was published in 2007. This instrument, developed on the
biasis of the Oxman-Guyatt Overview Quality Assessment
Questionnaire (OQAQ) [11] and Sack’s Quality Assessment
Checklist [12] is considered a validated tool in assessing the
methodological quality of systematic reviews, and receives
recognition from international agencies, including The Canadian
Agency for Drugs and Technologies in Health (CADTH) [13].
Our study therefore aims to address the limitations of published
studies, by assessing epidemiological and reporting characteristics,
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Chinese medicine. We will particularly employ the new instru-
ments for assessing the quality of reporting and methodological
quality of those reviews.
Methods
Inclusion Criteria
We included all systematic reviews about TCM published in
Chinese Journals. TCM interventions may have included herbal
medicine, acupuncture/acupressure, moxibustion, Tuina massage,
food therapy, and physical exercise such as tai chi and shadow
boxing. TCM interventions may have been administered alone or
in combination with conventional western medicine. We included
publications described as systematic reviews or those that provided
an overview of evidence from multiple studies and where authors
described their methods in explicit detail.
Search Strategy(Text S1)
Four Chinese databases (Chinese Biomedicine Literature
Database (CBM), Chinese Scientific Journal Full-text Database
(CSJD), Chinese Journal Full-text Database (CJFD), and Wanfang
Database) were searched from inception through Dec 2009. The
search terms included ‘‘Systematic Review’’, ‘‘Meta-analysis’’,
‘‘Traditional Chinese Medicine’’ and ‘‘Chinese herbs’’ etc.
Screening
Two researchers independently screened the titles and abstracts
of identified studies. One reviewer subsequently screened the full
text articles of potentially included studies (Jiwu GUO) while a
second reviewer independently screened a 20% random sample
(Bin MA). Disagreement was resolved by discussion.
Data Collection and Analysis
Variables extracted included publication and reporting charac-
teristics as well as items from the PRISMA and AMSTAR
checklists. Reviews were classified according to their TCM focus
as Herbal (e.g. bulk herbs, decoctions, pills) or Non-herbal (e.g.
acupuncture, Tuina). Conditions studied were classified using the
International Classification of Diseases (ICD-10). Data was
collected using a standardized form and summarized using
descriptive statistics (frequency, median, interquartile range
(IQR)). Analyses were performed using Excel (version Microsoft
Excel 2003; http://office.microsoft.com/zh-cn/) and SPSS (ver-
sion 13.0; http://www.spss.com).
Results
Search
The searches identified 10,001 records. Screening excluded
9,621 reviews due to duplication, focus on non-TCM interven-
tions, or for not being a SR. After examination of the full texts of
380 article, a further 11 reviews were excluded because they were
quality assessments of systematic reviews and meta-analyses. A
total of 369 publications were included (Figure 1, Text S2).
Epidemiological Characteristics (Table 1)
The 369 reviews were all written in Chinese and were published
in 145 different Chinese Journals. Frequency of citation of each
review ranged from 0 to 79; nearly half (46.1%) had not been cited
and only 2.4% had been cited more than 15 times. Almost half
(49.9%) of the reviews were written by clinicians. The reviews were
classified as either Herbal interventions (84.3%) or Non-Herbal
interventions. Non-herbal interventions included acupuncture
(14.6%) and Tuina (1.1%). The most common conditions studied
were diseases of the circulatory system (6.5%) and digestive system
(5.7%).
Descriptive Characteristics (Table 2)
The reviews included a median of three authors (IQR: 2.0–5.0).
Almost half the reviews (47.7%) were published in specialty
journals although this differed significantly between reviews of
herbal and non-herbal interventions (79.0% versus 21.0%,
Figure 1. Flow chart of articles identified, included and excluded. SRs, Systematic Review.
doi:10.1371/journal.pone.0020185.g001
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Category Characteristic Number (%) of n=369
Number of times cited 0 170 (46.1)
1–5 137 (37.1)
6–10 41 (11.1)
11–15 12 (3.3)
.15 9 (2.4)
Role of first author Clinician 184 (49.9)
Researcher 82 (22.2)
Graduate student 54 (14.6)
Other 49 (13.3)
Focus of reviews Chinese Herbal Interventions
a 314 (84.3)
Non-Herbal Interventions
b 55 (15.7)
Condition focused on in review (Common ICD-10
c) Diseases of the circulatory system 24 (6.5)
Diseases of the digestive system 21 (5.7)
Diseases of the nervous system 18 (4.9)
Diseases of the genitourinary system 17 (4.5)
Diseases of the respiratory system 11 (3.0)
Diseases of the blood and blood-forming organs and immune
mechanism
14 (3.8)
Diseases of the musculoskeletal system and connective tissue 9 (2.4)
Mental and behavioural disorders 9 (2.4)
Diseases of the skin and subcutaneous tissue 5 (1.4)
Endocrine, nutritional and metabolic diseases 5 (1.4)
Neoplasms 5 (1.4)
Infectious and parasitic diseases 3 (0.8)
Pregnancy, childbirth and the puerperium 2 (0.5)
Diseases of the ear and mastoid process 1 (0.3)
Diseases of the eye and adnexa 1 (0.3)
Symptoms, signs and abnormal clinical and laboratory
findings, not classified elsewhere
1 (0.3)
aHerbal interventions included bulk herbs, decoctions, pills;
bNon-herbal interventions included acupuncture and Tuina;
cCommon ICD-10: International Classification of Diseases 10.
doi:10.1371/journal.pone.0020185.t001
Table 2. Descriptive Characteristics of Included Systematic Reviews.
Category All SRs n=369 Herbal SRs
a n=314 Non-herbal SRs
b n=55
Number of authors, Median (IQR) 3 (2–5) 3.0 (2–4) 4 (3–5)
Journal type* General, n (%) 193 (52) 175 (91) 18 (9)
Specialty, n (%) 176 (48) 139 (79) 37 (21)
Indexed in CSCD
c Yes n (%)* 120 (33) 91 (76) 29 (24)
Number of included studies
Median (IQR)*
10 (7–17) 11 (7–19) 8 (6–13)
Number of participants in included studies Median (IQR) 952 (562–1596) 1004 (583–1789) 890 (534–1273)
Meta-analysis Yes (%) 343 (93) 292 (93) 51 (93)
Update of a previous review n (%) 0 (0) 0 (0) 0 (0)
aHerbal interventions included bulk herbs, decoctions, pills;
bNon-herbal interventions included acupuncture and Tuina;
cCSCD: Chinese Science Citation Database;
*indicates p,0.05.
doi:10.1371/journal.pone.0020185.t002
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journals cited by Chinese Science Citation Database (CSCD),
which again varied significantly between herbal and non-herbal
interventions (p,0.05). The reviews included a median of 10.0
studies each, involving 951.5 participants. Non-herbal SRs
included significantly fewer studies (p,0.05) and participants
compared to herbal SRs. Meta-analysis was conducted in almost
all the reviews (93.0%) and did not differ significantly between
groups. None of the reviews had been updated from a previous
review.
PRISMA Checklist Assessment (Table 3)
Compliance with PRISMA checklist items ranged from 0–
97.6%. Almost all reviews (97.6%) described themselves using the
terms ‘‘systematic review’’ or ‘‘meta analysis’’. Most reviews were
compliant with the following checklist items: included a clear
rationale, described information sources, described method used
for assessing risk of bias of individual studies, stated the principle of
summary measures, described the results of individual studies,
discussed limitations at study and outcome level, provided a
general interpretation of results, and presented an available
conclusion. More than half of reviews were compliant with the
following checklist items: reported eligibility criteria, presented
search strategy, stated the process for selecting studies, specified
any assessment of risk of bias that may affect the cumulative
evidence, described characteristics of included studies, or de-
scribed risk of bias within studies. Less than half of reviews were
compliant with the following checklist items: described data
collection process, described synthesis of results, described
additional analysis, described how the studies were selected,
presented synthesis of results (although this varied across reviews
category), presented results of any assessment of risk of bias across
studies, or described sources of funding and other support. Few
studies provided a description of objectives or purpose, lists of data
items, or gave results of additional analysis. None of the studies
provided a structured summary, protocol or registration informa-
tion, or provided a summary of results in the discussion.
AMSTAR Checklist Assessment (Table 4)
Compliance with AMSTAR checklist items ranged from 0–
70.2%. More than half of reviews were compliant with the
following checklist items: reported that a comprehensive literature
Table 3. PRISMA Assessment of Reporting Characteristics.
Category Item (Yes)
Overall, n=369
n( % )
Herbs
a n=314
n( % )
Non-herbs
b n=55n
(%)
TITLE 1. Title 360 (97.6) 308 (98.1) 52 (94.6)
ABSTRACT 2. Structured summary 0 (0.0) 0 (0.0) 0 (0.0)
INTRODUCTION 3. Rationale 344 (93.2) 292 (93.0) 52 (94.6)
4. Objectives 74 (20.1) 61 (19.4) 13 (23.6)
METHODS 5. Protocol and registration 0 (0.0) 0 (0.0) 0 (0.0)
6. Eligibility criteria 214 (58.0) 185 (58.9) 29 (52.7)
7. Information sources* 363 (72.1) 217 (69.1) 49 (89.1)
8. Search* 208 (56.4) 165 (52.6) 43 (78.2)
9. Study selection* 244 (66.1) 215 (68.5) 29 (52.7)
10. Data collection process* 160 (43.4) 127 (40.5) 33 (60.0)
11. Data items* 52 (14.1) 35 (11.2) 17 (30.9)
12. Risk of bias in individual studies* 265 (71.8) 212 (67.5) 43 (78.2)
13. Summary measures* 275 (74.5) 228 (72.6) 47 (85.5)
14. Synthesis of results 143 (38.8) 126 (40.1) 17 (30.9)
15. Risk of bias across studies 196 (53.1) 173 (55.1) 23 (41.8)
16. Additional analyses 137 (37.1) 121 (38.5) 16 (29.1)
RESULTS 17. Study selection* 166 (45.0) 149 (47.5) 17 (30.9)
18. Study characteristics 224 (60.7) 189 (60.2) 35 (63.6)
19. Risk of bias within studies 227 (61.5) 187 (59.6) 40 (72.7)
20. Results of individual studies 295 (80.0) 251 (79.9) 44 (80.0)
21. Synthesis of results* 171 (46.3) 153 (48.7) 18 (32.7)
22. Risk of bias across studies 151 (40.9) 133 (42.4) 18 (32.7)
23. Additional analysis 78 (21.1) 71 (22.6) 7 (12.7)
DISCUSSION 24. Summary of evidence 0 (0.0) 0 (0.0) 0 (0.0)
25. Limitations 346 (93.8) 296 (94.3) 50 (90.9)
26. Conclusions 339 (91.9) 288 (91.7) 51 (92.7)
FUNDING 27. Funding 144 (39.0) 119 (37.9) 25 (45.5)
aHerbal interventions included bulk herbs, decoctions, pills;
bNon-herbal interventions included acupuncture and Tuina;
*indicates p,0.05.
doi:10.1371/journal.pone.0020185.t003
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studies, assessed and documented the scientific quality of the
included studies, or appropriately addressed the quality of
included studies in formulating conclusions. Less than half of
reviews were compliant with the following checklist items: reported
that there were duplicated study selection and data extraction,
used appropriate methods to combine the findings of studies
(although this varied across reviews category), or assessed the
likelihood of publication bias. Few studies provided an ‘a priori’
design, reported the status of publication used as an inclusion
criterion, provided a list of studies, or stated if there was a conflict
of interest or not. .
Discussion
Our study identified 369 systematic reviews of TCM interven-
tions published since 1999, most of which evaluated herbal
interventions. This study updates previous reviews of this topic
[6,7,8] by including an additional 258 SRs. This review is also the
first to examine compliance of Chinese SR authors with the
PRISMA reporting guideline and AMSTAR tool for assessing
methodological quality.
Our review examined some of the same variables described in
Moher et al.’s investigation of SRs written in English and indexed
in Medline [5]. In that study, the authors reported that the 300
SRs they included were published in 132 journals, including the
Cochrane Library. In contrast to our review, only 8% of their
included SRs were of complementary and alternative medicine
(CAM) interventions. While most (91%) of their SRs were
published in specialty journals, 45% of all 132 journals did not
have an impact factor. Most (93%) of our SRs included a meta-
analysis compared to 54% of the English studies and while 44% of
our studies assessed for publication bias, only 23% of the English
studies reporting doing so. Funding sources were reported in 39%
of our studies compared to 59% of the English studies.
The range of diseases addressed in our reviews are similar with
those in the three reviews [6,7,8] focusing on the Chinese
literature. The three reviews, however, failed to report details
about the epidemiological and study characteristics of systematic
reviews, including number of times cited, journal type, number of
studies included, number of participants, and whether it is an
update of a published review. Moreover, one study [6] did not
report the prevalence of reviews meeting each individual item of
QUOROM. In addition we found that, despite the increasing use
of the terms ‘‘systematic review’’ and ’’meta-analysis’’ in the title
and subsequent manuscript sections, the quality of reporting
remains poor.
While many deficits in reporting were evident in the Chinese
SRs, we identified areas of particular concern. These included
evidence that suggested that the SRs were not highly referenced by
other researchers working in the same field. This may be due, in
part, to the overall poor quality of this body of work, which may
also be a reason that less than one third were indexed in the
Chinese Science Citation Database (CSCD), which is similar to
the Science Citation Index, in that indexed journals are considered
of higher quality than non-indexed journals.
There is also evidence that even though SRs have become an
increasingly popular source of up-to-date knowledge, they are
under utilized by Chinese clinicians. Because although the Chinese
Cochrane Center was established in 1997 by the Ministry of
Health of the people’s republic of China, recent studies reported
that most clinicians and nurses had not heard of or did not
understand the meaning of evidence-based medicine (EBM)
[14,15]. In addition, not all medical schools have introduced
EBM curricula in China.
Although it is well known that results from reviews are most
useful when they are up-to-date [16], none of the reviews included
in our SR reported being an update of a previous review. This
may be due to lack of policies in China to encourage updates and
reluctance of Chinese journals to publish updated reviews that are
not substantially different from previous publications. The review
by Moher et al. reported that 18% of the English SRs were
updates, however, only those SRs published in the Cochrane
Library had been updated [5], suggesting that this problem is not
restricted to Chinese journals.
We have demonstrated that compliance with PRISMA
reporting guidelines is low for many Chinese SRs. Items of
particular concern included lack of appropriate abstracts or
Table 4. AMSTAR Assessment of Methodological Characteristics.
Category (Yes)
Overall,
n=369 n (%)
Herbs, n=314
n( % )
Non- herbal
interventions, n=55
n( % )
1. Was an ‘a priori’ design provided? 19 (5.2) 17 (5.4) 2 (3.6)
2. Was there duplicate study selection and data extraction? * 152 (41.2) 120 (38.2) 32 (58.2)
3. Was a comprehensive literature search performed? * 203 (55.0) 159 (50.6) 44 (80.0)
4. Was the status of publication (i.e. grey literature) used as an inclusion criterion? 10 (2.7) 9 (2.9) 1 (1.8)
5. Was a list of studies (included and excluded) provided? 13 (3.5) 10 (3.2) 3 (5.5)
6. Were the characteristics of the included studies provided? 221 (59.9) 182 (58.0) 39 (70.9)
7. Was the scientific quality of the included studies assessed and documented? 259 (70.2) 219 (69.8) 42 (76.4)
8. Was the scientific quality of the included studies used appropriately in formulating
conclusions?
254 (68.8) 212 (67.5) 40 (72.7)
9. Were the methods used to combine the findings of studies appropriate? * 108 (29.3) 100 (31.9) 8 (14.6)
10. Was the likelihood of publication bias assessed? * 161 (43.6) 147 (46.8) 14 (25.5)
11. Was the conflict of interest stated? 30 (8.1) 27 (8.6) 3 (5.5)
a Herbal interventions included bulk herbs, decoctions, pills;
b Non-herbal interventions included acupuncture and Tuina;
*indicates p,0.05.
doi:10.1371/journal.pone.0020185.t004
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evidence. In order to improve the quality of reporting, we strongly
recommend the use of reporting guidelines by authors. We also
recommend that editors of medical journals recognize and
promote use of reporting guidelines in their publications. Lastly,
medical schools should introduce reporting guidelines into medical
education as early as possible.
Reviews of numerous medical specialties, as well as comprehen-
sive reviews, have concluded that the quality of SR and meta-
analysis (MA) reporting is generally poor [6,7,17]. Examination of
changes in reporting quality of MAs published in Medline, Embase
and the Cochrane Database of Systematic Reviews, suggested that
quality had improved after the release of the QUORUM reporting
guidelines [18,19]. We anticipate that increased use of PRISMA by
Chinese authors will be helpful in increasing the reporting quality of
SRs published in Chinese journals.
Our study has also shown that the methodological quality of
Chinese SRs of TCM is poor. Areas of particular concern include
lack of report of an ‘a priori’ design, description of status of
publication used as an inclusion criterion, as well as statement of
conflict of interest, all factors which may be associated with biased
results. In addition, statistical mistakes appeared in one-third
(29.3%) of reviews. For instance, many reviews did not explore
reasons for statistical heterogeneity but simply pooled results using a
random effects model to account for heterogeneity. Where
heterogeneity is substantial, an overall pooling of results may be
inappropriateand mayleadtotheincorrectinterpretationofresults.
One explanation for limited compliance with methodological
guidelines may be that AMSTAR has not been published or
promoted in Chinese journals outside of a brief abstract published
in the Chinese Journal of Evidence-based Medicine in September
2010 [20]. Broader promotion of methodological quality guide-
lines is a necessary step in enhancing dissemination and
implementation of AMSTAR.
However, our study has limitations. First, the majority of articles
failed to follow the PRISMA guideline. This is likely due to the fact
that the PRISMA guideline had not yet been released at the time
these studies were published. Second, our study included systematic
reviews published only in Chinese journals, whereas Chinese
investigators increasingly publish articles in international journals.
Third, we have found differential results between systematic reviews
addressing herbal versus non-herbal medicines. This is possibly
because reviews addressing non-herbal medicines would have
studies with fewerevents,resultinginabsenceof statistical difference
of comparisons. Last, in our search, we included the terms
‘‘systematic review’’ and ‘‘meta-analysis’’. Some potentially eligible
systematic review (i.e., systematic reviews needs to be plural) may,
however, not use these terms in their publications.
Our purpose was to provide readers with a broad overview of the
reporting and methodological characteristics of SRs of TCM
published in Chinese journals. Although many such SRs have been
published, the quality of these reviews is troubling. As a potential
key source of information for clinicians and researchers, not only
were many of these reviews incomplete, some contained mistakes or
were misleading. Focusing on improving the quality of SRs of
TCM, rather than continuing to publish them in great quantity, is
urgently needed in order to increase the value of these studies.
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